An 83-year-old patient developed agranulocytosis following six months of enalapril 10 mg/d. The patient also had received verapamil for three years. Upon discontinuation of both drugs the white blood cell count was rapidly restored. Cases of agranulocytosis due to angiotensin-converting enzyme inhibitors, mainly captopril, have been previously described. We could, however, find no single case associated with verapamil. This, and the very long exposure of the patient to verapamil, support the assumption that this life-threatening complication might have been caused by enalapril.
Get full access to this article
View all access options for this article.
References
1.
WilliamsGH. Converting enzyme inhibitors in the treatment of hypertension. N Engt J Med1988; 319: 1517–25.
2.
BreckenridgeA. Angiotensin converting enzyme inhibitors. Br Med J1988; 296: 618–20.
3.
JaeschkeRGuyattGH. Medical therapy for chronic congestive heart failure. Ann Intern Med1989; 110: 758–60.
4.
PackerM. Therapeutic options in the management of chronic heart failure. Is there a drug of first choice?Circulation1989; 79: 198–204.
5.
The Consensus Trial Study Group.Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med1987; 316: 1429–35.
6.
IrvinJDViauJM. Safety profiles of the angiotensin converting enzyme inhibitors captopril and enalapril. Am J Med1986; 81 (suppl 4C):46–50.
7.
ToddPAHellHC. Enalapril. Drugs1986; 31: 198–248.
8.
DavisROIrvinJDKramschDKWolkerJFMonchoaF. Enalapril world wide experience. Am J Med1984; 77 (suppl 2A):23–35.
9.
StuderAVetterW. Reversible leukopenia associated with angiotensin CE inhibitor MK-421 (letter). Lancet1982; 1: 458.
10.
JandlJH. Leucocyte anomalies. In: JandlJH. ed. Blood, textbook of hematology. 1st ed.Boston: Little Brown. 1987: 571–88.
11.
NeedlemanPCorrPBJohnsonEMJr. Drugs used for the treatment of angina: Organic nitrates, calcium channel blockers and beta-adrenergic antagonists. GilmanAGGoodmanLSRallTWMuradF. Goodman and Gilman's the pharmacological basis of therapeutics. 7th ed.New York: Macmillan. 1985: 806–26.
